GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,645,000 | +422.1% | 450,000 | +165.6% | 0.17% | +503.6% |
| Q1 2022 | $5,870,000 | +131.9% | 169,458 | +96.0% | 0.03% | +115.4% |
| Q4 2021 | $2,531,000 | -92.3% | 86,454 | -85.6% | 0.01% | -94.3% |
| Q3 2020 | $33,084,000 | -44.5% | 600,000 | -20.0% | 0.23% | -43.0% |
| Q4 2019 | $59,618,000 | -23.8% | 750,000 | -53.5% | 0.40% | -32.0% |
| Q3 2019 | $78,218,000 | +32.2% | 1,612,069 | +43.3% | 0.59% | +53.5% |
| Q2 2019 | $59,175,000 | -25.5% | 1,125,000 | -25.0% | 0.38% | -35.5% |
| Q1 2019 | $79,395,000 | +33.4% | 1,500,000 | +3.4% | 0.60% | +36.9% |
| Q4 2018 | $59,523,000 | +14.3% | 1,450,000 | +5.8% | 0.44% | +41.6% |
| Q3 2018 | $52,060,000 | -2.8% | 1,370,000 | +15.6% | 0.31% | -6.9% |
| Q2 2018 | $53,562,000 | +300.3% | 1,185,000 | +248.5% | 0.33% | +203.7% |
| Q4 2017 | $13,379,000 | – | 340,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |